Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X842 capsules vs lansoprazole for reflux esophagitis
CTR20192545Phase 2Completed
- Sponsor
- Tairui Shengnuo
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linaprazan glurate in erosive esophagitis (EE), sponsored by Tairui Shengnuo. Started Dec 2019; status: completed.
02
Drugs
linaprazan glurate
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20192545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192545.